摘要
磁性协助释放的治疗机制对于 包括磁性药物命中,在一些研究中,成为有前景的治疗策略。相比其他命中策略它的一个显著优势是它有显著使命后控制远程的释放和集聚纳米载体的可能性。然而,有效的准备和强劲的磁性载体的回应基于永久氧化铁纳米水晶依然代表一个巨大的科学挑战,因为个别SPION存在高的磁性空间梯度。一个克服策略是SPION簇取得足够的磁性回应。在这个简短的综述中,我们指出当代和未来的策略设计和制定磁性回应纳米载体,基于SPION为磁性靶点药物的释放,包括基本的物理要求,药物着陆可能性和控制药物在目标区域的释放。
关键词: 磁性纳米粒,纳米簇,磁性药物释放,铁氧化物纳米晶体,SPION簇,磁性命中,磁性纳米载体,磁性辅助释放。
Current Medicinal Chemistry
Title:Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery
Volume: 24 Issue: 5
关键词: 磁性纳米粒,纳米簇,磁性药物释放,铁氧化物纳米晶体,SPION簇,磁性命中,磁性纳米载体,磁性辅助释放。
摘要: Magnetically-assisted delivery of therapeutic agents to the site of interest, which is referred to as magnetic drug targeting, has proven to be a promising strategy in a number of studies. One of the key advantages over other targeting strategies is the possibility to control remotely the distribution and accumulation of the nanocarriers after parenteral administration. However, preparation of effective and robust magnetically responsive nanocarriers based on superparamagnetic iron oxide nanocrystals (SPIONs) still represents a great scientific challenge, since spatial guidance of individual SPIONs is ineffective despite the presence of high magnetic field gradient. A strategy to overcome this issue is the clustering of SPIONs to achieve sufficient magnetic responsiveness. In this mini-review, we address current and future strategies for the design and fabrication of magnetically responsive nanocarriers based on SPIONs for magnetically-targeted drug delivery, including the underlying physical requirements, the possibility of drug loading, and the control of drug release at the targeted site.
Export Options
About this article
Cite this article as:
Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery, Current Medicinal Chemistry 2017; 24 (5) . https://dx.doi.org/10.2174/0929867323666160813211736
DOI https://dx.doi.org/10.2174/0929867323666160813211736 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypergonadotropic Hypogonadism: Management of Infertility
Current Pharmaceutical Design Genetic Polymorphisms in UDP-Glucuronosyltransferase 1A6 Are Not Associated with NSAIDs-Related Peptic Ulcer Haemorrhage
Drug Metabolism Letters Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders
CNS & Neurological Disorders - Drug Targets Novel Drugs for Neuroblastoma
Drug Design Reviews - Online (Discontinued) Electroporation Gene Therapy: New Developments In Vivo and In Vitro
Current Gene Therapy Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives
Current Medicinal Chemistry Targeting Histone Deacetylases in Neuroblastoma
Current Pharmaceutical Design Patent Selections
Recent Patents on Biotechnology Corticosteroids for the Inflammatory Response to Cardiopulmonary Bypass: An Update
Current Pharmaceutical Design Possible Roles of Microglial Cells for Neurotoxicity in Clinical Neurodegenerative Diseases and Experimental Animal Models
Inflammation & Allergy - Drug Targets (Discontinued) Current and Future Chemotherapy for Chagas Disease
Current Medicinal Chemistry Trafficking of Natural Killer Cells
Current Molecular Medicine Relative Dominance of Env-gp41-Specific Cytotoxic T Lymphocytes Responses in HIV-1 Advanced Infection
Current HIV Research Immunological Approaches for HIV Therapy
Current Drug Targets - Infectious Disorders Anti-TNFs for Postoperative Recurrence in Crohns Disease: The Ifs and Hows
Current Drug Targets Fatty Acid-Mediated Inhibition of Metal Binding to the Multi-Metal Site on Serum Albumin: Implications for Cardiovascular Disease
Current Topics in Medicinal Chemistry Contribution of NRF2 in Gastrointestinal Protection from Oxidative Injury
Current Pharmaceutical Design Toll-Like Receptors, Cytokines and the Immunotherapeutics of Asthma
Current Pharmaceutical Design Lichen Depsidones as Potential Novel Pharmacologically Active Compounds
Mini-Reviews in Organic Chemistry Anti-tumorigenic Efficacy of Tangeretin in Liver Cancer – An In Silico Approach
Current Computer-Aided Drug Design